About this trial
The purpose of this study is to compare the advantages and disadvantages of two approaches for quitting smoking among people living with HIV (PWH). Participants will complete a 24- week (\~6-month) study where the Participants will be assigned to one of two smartphone apps to help with quitting smoking. Regardless of the group participants are assigned to, they will also receive a combination of nicotine replacement therapy (patches and gums) that have been shown to help people quit smoking. The main questions this study aims to answer are:
Participants will complete 5 video call visits over about 6 months. Participants will install their assigned smoking cessation app onto their phone and will be asked to use the app for the duration of the study along with their provided Nicotine Replacement Therapy (NRT) products. During the study visits, participants will meet with study staff to complete questionnaires and interviews. Participants may be asked to provide breath and saliva samples to measure the level of carbon monoxide and nicotine.
Eligibility criteria
Qualifiers
Self-reported daily cigarette smoking over the past 30 days
Self-reported HIV status
Age 18 or older
Desire to quit smoking
Disqualifiers
Current acute psychotic episode or unsafe to participate in the study
Pregnant or intending to become pregnant in the next 6 months
Currently receiving any pharmacological and/or behavioral intervention or counseling for smoking cessation
Any medical condition or medication that could compromise subject safety, as determined by the PIs and/or study physician
Trial design
Treatments tested in this trial
- Learn to Quit-HIV (LTQ-H) App
- QuitStart
Treatment groups
Sponsors and collaborators
Wake Forest University Health Sciences
Lead sponsor
University at Buffalo
Collaborator
National Institutes of Health (NIH)
Collaborator
National Cancer Institute (NCI)
Collaborator